Suppr超能文献

[儿童连续硬膜外麻醉时布比卡因的血浆浓度]

[Plasma concentrations of bupivacaine for continuous peridural anesthesia in children].

作者信息

Scherhag A, Kleemann P P, Vrana S, Stanek A, Dick W

机构信息

Klinik für Anästhesiologie der Johannes Gutenberg-Universität Mainz.

出版信息

Anaesthesist. 1998 Mar;47(3):202-8. doi: 10.1007/s001010050548.

Abstract

Epidural anaesthesia is extremely useful in providing postoperative analgesia for children after surgery of the lower body. Although results on early pharmacokinetics in children have previously been reported, no data are available on the long-term effects of epidural anaesthesia. The aim of this investigation was the assessment of plasma bupivacaine levels in children with continuous epidural anaesthesia in the postoperative period. A catheter with an outer diameter of 0.63 mm was inserted through a 19G Tuohy cannula into the epidural space. A maximum dose of 0.4 mg/kg/h bupivacaine was administered for continuous epidural infusion. Careful monitoring was performed to detect early signs of local anaesthetic intoxication. Two milliliters of blood were obtained in each patient per day and nepholometric serum measurement were performed to determine alpha 1-acid glycoprotein and albumin levels. Bupivacaine plasma concentrations were assessed according to the method described by Sattler et al. [25]. Ten children were included in the investigation. The measured albumin and alpha 1-acid glycoprotein concentrations were within the range described by other investigators. At the onset of pain therapy maximum levels of 0.5 microgram/ml were recorded after a loading dose of bupivacaine and levels of up to 2.2 micrograms/ml were achieved following continuous infusion. There were no neurologic complications or signs of local anesthetic intoxication. In conclusion our results show that a dose of up to 0.4 mg/kg/h bupivacaine during continuous epidural infusion is not associated with toxic complications. Careful monitoring of the children by experienced staff is mandatory.

摘要

硬膜外麻醉对于为儿童下半身手术后提供术后镇痛极为有用。尽管此前已有关于儿童早期药代动力学的报道,但尚无硬膜外麻醉长期影响的数据。本研究的目的是评估术后持续硬膜外麻醉儿童的血浆布比卡因水平。将外径为0.63毫米的导管通过19G Tuohy套管插入硬膜外间隙。布比卡因持续硬膜外输注的最大剂量为0.4毫克/千克/小时。进行仔细监测以检测局部麻醉药中毒的早期迹象。每天从每位患者采集2毫升血液,并进行比浊法血清测量以测定α1-酸性糖蛋白和白蛋白水平。根据Sattler等人[25]描述的方法评估布比卡因血浆浓度。10名儿童纳入本研究。测得的白蛋白和α1-酸性糖蛋白浓度在其他研究者描述的范围内。在疼痛治疗开始时,布比卡因负荷剂量后记录到的最高水平为0.5微克/毫升,持续输注后达到高达2.2微克/毫升的水平。未出现神经并发症或局部麻醉药中毒迹象。总之,我们的结果表明,持续硬膜外输注期间布比卡因剂量高达0.4毫克/千克/小时与毒性并发症无关。必须由经验丰富的工作人员对儿童进行仔细监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验